摘要
目的:从微观指标和临床症状两方面创建经前期综合征肝气逆证临床疗效评价参考标准。方法:采用流行病学前瞻研究方法,连续跟踪观察受试者3个月经周期对经前平组和安慰剂组进行疗效观察。结果:DRSP、"PMS肝气逆证症状严重程度医生评价表"和"PMS肝气逆证症状严重程度患者自评表"各条目及总分,在治疗前、治疗中和治疗后比较差异有统计学意义,反映疗效评价的灵敏指标显著改变。结论:从临床症状和微观指标两方面可以建立PMS肝气逆证疗效评价的参考标准。
Objective: To establish reference standards of treatment effect of liver-qi invasion of premenstrual syndrome from macro and micro aspects. Methods: Adopt epidemiology prospective to observe receiver during three menstrual cycle,screened macro-symptoms and micro-sensitive indexes of treatment effect,and observe treatment effect of Jing Qianping group and placebo group. Results: There were significant differences before,medium and after treatment,which were entries and score of DRSP,"Premenstrual Syndrome of Invasion of the Hyperactive Liver-qi of Symptoms Serious Degree Doctor Evaluation Scale"and"Premenstrual Syndrome of Invasion of the Hyperactive Liver-qi of Symptoms Serious Degree Patient Evaluation Scale ". Conclusion: Established reference standards of treatment effect of Premenstrual Syndrome of Invasion of the Hyperactive Liver-qi can be established from macro-symptoms and micro-indexes.
作者
高冬梅
高明周
安礼
王海军
王杰琼
张惠云
乔明琦
GAO Dong-mei;GAO Ming-zhou;AN Li;WANG Hai-jun;WANG Jing-qiong;ZHANG Hui-yun;QIAO Ming-qi(Institute of basic theory of traditional Chinese medicine of Shandong University of Traditional Chinese Medicine, Jinan 250355, China;College of traditional Chinese medicine of Shandong University of Traditional Chinese Medicine, Jinan 250355, China;Jinan Central Hospital, Jinan 250013, China)
出处
《中国中医基础医学杂志》
CAS
CSCD
北大核心
2018年第5期620-623,647,共5页
JOURNAL OF BASIC CHINESE MEDICINE
基金
科技部"十五攻关"项目资助课题(2004BA721A04)-经前期综合征肝气逆证辨证规范与疗效评价标准研究
关键词
经前期综合征
肝气逆证
疗效评价
量表
评价标准
Premenstrual syndrome
Liver-qi invasion syndrome
Efficacy evaluation
Scale
Evaluation criteria